NEW ORLEANS and CAMBRIDGE, Mass. — Obatala Sciences, a biotechnology company that manufactures stem cell and hydrogel products to enable next-generation therapeutics discovery, has been granted an exclusive license from Harvard University to commercialize innovations that enable the study of human fat tissue in vitro. Obatala and Harvard Office of Technology Development announced the agreement today. Obatala […]
Yokogawa will co-innovate with industry leaders to advance biopharmaceutical development and manufacturing. Houston, Texas — Yokogawa Corporation of America announces that the company has joined the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) as an industry member. Yokogawa will contribute expertise in bioreactor process control and automation through interaction with universities, industry-leading researchers and […]
EMERYVILLE, Calif. — Today, Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, announced the release of its TechAccess Subscription model to enable broader customer access to their cutting-edge, single-cell screening technology. The new offering brings requested volume and throughput flexibility to customers who want to access the company’s cell line development and […]
Vancouver, Canada-based Precision NanoSystems (PNI) provides technology solutions enabling the development and manufacturing of lipid nanoparticles for the delivery of genetic medicines, including mRNA PNI will join Danaher’s Life Sciences platform, complementing the portfolios of Cytiva and Pall Precision NanoSystems (PNI) has been acquired by Danaher Corporation’s Life Sciences platform. PNI is a global leader in technologies […]
HAMPTON, N.J. — Liver toxicity is one of the manifestations of toxicological effects from pharmaceutical compounds and is a leading reason for drug attrition. The identification of potential toxicity at an early stage in drug discovery can save time and developmental costs, and most importantly reduce the likelihood of late-stage failure. Early identification of the toxicological […]
Largest organ-on-a-chip screen on a 3D angiogenesis assay Leiden – MIMETAS, the global leader in human-relevant organ-on-a-chip models, has just opened their Phenotypic Screening Center. The center facilitates large-scale screening campaigns on Organ-on-a-Chip models, a powerful technology that improves the human physiological relevance of cultured tissues by utilizing microfluidic techniques. In contrast to other Organ-on-a-Chip […]
Amsterdam, the Netherlands — In its effort to develop effective cellular immunotherapies for cancer treatment, the Regensburg Center for Interventional Immunology (RCI) in Germany has purchased LUMICKS’ z-Movi® Cell Avidity Analyzer. The placement highlights the promise of measuring cell avidity between immune cells and their tumor targets to improve the selection of chimeric antigen receptors (CARs) […]
DEPArray™ PLUS – the new automated and versatile platform to investigate pre-selected rare cell populations from various samples with 100% purity, now enhanced with 9 fluorescent channels and remarkably improved user experience BOLOGNA, Italy and HUNTINGDON VALLEY, Pa. – Menarini Silicon Biosystems, a pioneer of liquid biopsy and single cell technologies, announced today the launch […]
Corning expands cell culture portfolio with 3D liver models that better recapitulate in vivo behavior and deliver a more physiologically relevant model for improved drug safety and efficacy screening CORNING, N.Y. — Corning Incorporated (NYSE: GLW) today announced the launch of its HepGo™ Assay-ready 3D liver spheroid kit, the first plug-and-play solution to include 96 […]
• Creating a fully automated robotic system will bring industrial scale reliability to cell therapy manufacturing while providing speed and flexibility • Automation readily used in other industries is now being tested in the cell therapy workflow • Technology has the potential to transform global healthcare as more cell therapies receive regulatory approval around the […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
